Anthony Mastracchio

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Epithelial Mesenchymal Transition

Diffuse Large B Cell Lymphoma

Top Venues

Molecular cancer therapeutics

ACS medicinal chemistry letters

The Journal of organic chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua P Plotnik, Adam E Richardson, Haopeng Yang, Estela Rojas, Velitchka Bontcheva, Colleen Dowell, Sydney Parsons, Ashley Wilson, Vida Ravanmehr, Christine Will, Paul M Jung, Haizhong Zhu, Sarathy Karunan Partha, Sanjay C Panchal, Raghuveer Singh Mali, Frederick J Kohlhapp, Ryan A McClure, Cyril Y Ramathal, Mariam D George, Manisha Jhala, Nathaniel L Elsen, Wei Qiu, Russell A Judge, Chin Pan, Anthony Mastracchio, Jared Henderson, Jonathan A Meulbroek, Michael R Green, William N Pappano
Inhibition of MALT1 and BCL2 induces synergistic anti-tumor activity in models of B cell lymphoma. Molecular cancer therapeutics (2024)
Joshua P Plotnik, Adam E Richardson, Haopeng Yang, Estela Rojas, Velitchka Bontcheva, Colleen Dowell, Sydney Parsons, Ashley Wilson, Vida Ravanmehr, Christine Will, Paul M Jung, Haizhong Zhu, Sarathy Karunan Partha, Sanjay C Panchal, Raghuveer Singh Mali, Frederick J Kohlhapp, Ryan A McClure, Cyril Y Ramathal, Mariam D George, Manisha Jhala, Nathaniel L Elsen, Wei Qiu, Russell A Judge, Chin Pan, Anthony Mastracchio, Jared Henderson, Jonathan A Meulbroek, Michael R Green, William N Pappano
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma. Molecular cancer therapeutics 23 (7) (2024)
Joshua P Plotnik, Adam E Richardson, Haopeng Yang, Estela Rojas, Velitchka Bontcheva, Colleen Dowell, Sydney Parsons, Ashley Wilson, Vida Ravanmehr, Christine Will, Paul M Jung, Haizhong Zhu, Sarathy Karunan Partha, Sanjay C Panchal, Raghuveer Singh Mali, Frederick J Kohlhapp, Ryan A McClure, Cyril Y Ramathal, Mariam D George, Manisha Jhala, Nathaniel L Elsen, Wei Qiu, Russell A Judge, Chin Pan, Anthony Mastracchio, Jared Henderson, Jonathan A Meulbroek, Michael R Green, William N Pappano
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma. Molecular cancer therapeutics 23 (7) (2024)
Joshua P Plotnik, Adam E Richardson, Haopeng Yang, Estela Rojas, Velitchka Bontcheva, Colleen Dowell, Sydney Parsons, Ashley Wilson, Vida Ravanmehr, Christine Will, Paul M Jung, Haizhong Zhu, Sarathy Karunan Partha, Sanjay C Panchal, Raghuveer Singh Mali, Frederick J Kohlhapp, Ryan A McClure, Cyril Y Ramathal, Mariam D George, Manisha Jhala, Nathaniel L Elsen, Wei Qiu, Russell A Judge, Chin Pan, Anthony Mastracchio, Jared Henderson, Jonathan A Meulbroek, Michael R Green, William N Pappano
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma. Molecular cancer therapeutics 23 (7) (2024)
Patrick B Brady, Bryan K Sorensen, Roberto M Risi, Michael L Curtin, Robert A Mantei, Alan S Florjancic, Anthony Mastracchio, Cheng Ji, Aaron R Kunzer, Chunqiu Lai, Gregory E Storer, Vincent S Chan, Rodger F Henry, Andrew J Souers, Michael R Michaelides, Andrew S Judd, T Matthew Hansen
Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467. The Journal of organic chemistry (2023)
Anthony Mastracchio, Chunqiu Lai, Enrico Digiammarino, Damien B Ready, Loren M Lasko, Kenneth D Bromberg, William J McClellan, Debra Montgomery, Vlasios Manaves, Bailin Shaw, Mikkel Algire, Melanie J Patterson, Chaohong C Sun, Saul Rosenberg, Albert Lai, Michael R Michaelides
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor. ACS medicinal chemistry letters 12 (5) (2021)
Yunsong Tong, Alan S Florjancic, Rick F Clark, Chunqiu Lai, Anthony Mastracchio, Gui-Dong Zhu, Morey L Smith, Peter J Kovar, Bailin Shaw, Daniel H Albert, Wei Qiu, Kenton L Longenecker, Xiaoqin Liu, Amanda M Olson, Donald J Osterling, Stephen K Tahir, Darren C Phillips, Joel D Leverson, Andrew J Souers, Thomas D Penning
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors. ACS medicinal chemistry letters 12 (7) (2021)